Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Complement component 2 deficiency (C2D) is a genetic condition that affects the immune system. Signs and symptoms include recurrent bacterial infections and risk for a variety of autoimmune conditions. Infections can be very serious and are common in early life. They become less frequent during the teen and adult years. The most frequent autoimmune conditions associated with C2D are lupus (10-20%) and vasculitis. C2D is caused by mutations in the C2 gene and is inherited in an autosomal recessive fashion.
Features include: Purpura and Systemic lupus erythematosus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 1 | Systemic lupus erythematosus |
C2 encodes complement C2 (752 aa). Precursor of the catalytic component of the C3 and C5 convertase complexes, which are part of the complement pathway, a cascade of proteins that leads to phagocytosis and breakdown of pathogens and signaling that strengthens the adaptive immune system.
Complement component 2 deficiency is associated with mutations in the C2 gene on chromosome 6.
The C2 protein participates in Creation of C4 and C2 activators and Defective F8 binding to the cell membrane pathways.
C2 is classified as a druggable target (Druggable Genome, Enzyme, and Protease categories) with score 0.6.
Genetic testing for C2 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for complement component 2 deficiency has been reported in the published literature.
No clinical trials have been registered for complement component 2 deficiency.
12 publications have been identified in PubMed for complement component 2 deficiency. Research spans Review / Meta-Analysis (25%), Case Report / Case Series (25%), and Basic Science / Preclinical (25%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 3 | 25% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:37 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about complement component 2 deficiency
Patient case studies
3 |
25% |
Laboratory research | 3 | 25% |
Testing and diagnosis research | 1 | 8% |
Clinical study results | 1 | 8% |
Disease patterns and progression | 1 | 8% |
Cetin O (2026). [PMID: 41358738](https://pubmed.ncbi.nlm.nih.gov/41358738/). *Blood advances*. [Clinical Trial Publication]
Cui J (2026). [PMID: 41674601](https://pubmed.ncbi.nlm.nih.gov/41674601/). *medRxiv : the preprint server for health sciences*. [Case Report / Case Series]
Justiz Vaillant AA (2026). [PMID: 29763203](https://pubmed.ncbi.nlm.nih.gov/29763203/). *Unknown Journal*. [Review / Meta-Analysis]
Bianchi C (2026). [PMID: 41807955](https://pubmed.ncbi.nlm.nih.gov/41807955/). *Pediatric rheumatology online journal*. [Case Report / Case Series]
Lan F (2025). [PMID: 39814882](https://pubmed.ncbi.nlm.nih.gov/39814882/). *Nature*. [Basic Science / Preclinical]
Donado CA (2025). [PMID: 39914456](https://pubmed.ncbi.nlm.nih.gov/39914456/). *Nature*. [Basic Science / Preclinical]
Ranjan N (2025). [PMID: 40385421](https://pubmed.ncbi.nlm.nih.gov/40385421/). *medRxiv : the preprint server for health sciences*. [Diagnostic / Biomarker]
Cresoe-Ortiz S (2024). [PMID: 39151691](https://pubmed.ncbi.nlm.nih.gov/39151691/). *The journal of allergy and clinical immunology. In practice*. [Epidemiology / Natural History]
Pinzon-Hoyos N (2024). [PMID: 39345496](https://pubmed.ncbi.nlm.nih.gov/39345496/). *bioRxiv : the preprint server for biology*. [Case Report / Case Series]
McMurray JC (2024). [PMID: 39294906](https://pubmed.ncbi.nlm.nih.gov/39294906/). *Allergy and asthma proceedings*. [Review / Meta-Analysis]